Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

FDA prevented 317 drug shortages in 2021

By Brian Buntz | June 23, 2022

FDA logoFDA worked with pharma companies to avert a record number of drug shortages in 2021 based on a recent report to Congress that tracked data starting in 2012 when the FDA Safety and Innovation Act (FDASIA) was passed.

In 2021, 115 manufacturers notified the FDA of 777 potential drug and biologic shortages.

Ultimately, the agency worked to prevent 317 drug shortages “through the use of a range of available tools, including regulatory flexibility and discretion when appropriate,” the report noted.

Drug shortages can be especially dangerous when they involve “a critical drug to treat cancer, to provide parenteral nutrition, or to address another serious medical condition, such as a shortage of blood pressure medications,” FDA explained in the report.

The report noted that the agency continues to keep a close watch on the medical product supply chain, which has grown less reliable during the pandemic.

The report notes that drug shortages quadrupled between 2005 and 2011, increasing from approximately 61 to 250.

Drug shortages have largely stabilized since 2013.

Drug shortages can result from several factors, including quality issues, a limited manufacturing capacity, and poor information sharing with supply chain organizations.

In addition, some hospitals react to drug shortages by hoarding.

To stop the shortages, FDA worked closely with manufacturers to find companies that could produce a drug in scarce supply and accelerated the pace of inspections and reviews to allow manufacturers to restart production.

The report also notes that the agency has stepped up its investigation of nitrosamine impurities as an example of how it works to ensure drug safety.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Pfizer-BioNTech vaccine vial
Pfizer, BioNTech moving forward on seeking COVID-19 vaccine EUA for youngest children
FDA logo
FDA curtails use of Janssen COVID-19 vaccine over blood clotting concerns
FDA logo
FDA sends warning letters to CBD and delta-8 THC product vendors
Pfizer logo
Pfizer recalls certain lots of blood-pressure drug Accupril

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards